BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 15645119)

  • 1. COX-2 correlates with F-box protein, Skp2 expression and prognosis in human gastric carcinoma.
    Honjo S; Kase S; Osaki M; Ardyanto TD; Kaibara N; Ito H
    Int J Oncol; 2005 Feb; 26(2):353-60. PubMed ID: 15645119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and biological significance of S-phase kinase-associated protein 2 (Skp2) gene expression in gastric carcinoma: modulation of malignant phenotype by Skp2 overexpression, possibly via p27 proteolysis.
    Masuda TA; Inoue H; Sonoda H; Mine S; Yoshikawa Y; Nakayama K; Nakayama K; Mori M
    Cancer Res; 2002 Jul; 62(13):3819-25. PubMed ID: 12097295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A selective cyclooxygenase-2 inhibitor, NS398, inhibits cell growth and induces cell cycle arrest in the G2/M phase in human esophageal squamous cell carcinoma cells.
    Kase S; Osaki M; Honjo S; Takeda A; Adachi K; Araki K; Ito H
    J Exp Clin Cancer Res; 2004 Jun; 23(2):301-7. PubMed ID: 15354416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High expression of S-phase kinase-interacting protein 2, human F-box protein, correlates with poor prognosis in oral squamous cell carcinomas.
    Kudo Y; Kitajima S; Sato S; Miyauchi M; Ogawa I; Takata T
    Cancer Res; 2001 Oct; 61(19):7044-7. PubMed ID: 11585732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of apoptosis and cell cycle arrest by NS398 in oral squamous cell carcinoma cells via downregulation of E2 promoter-binding factor-1.
    Du Y; Zhang S; Wang Z; Zhou W; Luan M; Yang X; Chen N
    Oncol Rep; 2008 Sep; 20(3):605-11. PubMed ID: 18695912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibited proliferation of cyclooxygenase-2 expressing human hepatoma cells by NS-398, a selective COX-2 inhibitor.
    Hu KQ; Yu CH; Mineyama Y; McCracken JD; Hillebrand DJ; Hasan M
    Int J Oncol; 2003 Apr; 22(4):757-63. PubMed ID: 12632065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased cyclooxygenase-2 expression in human squamous cell carcinomas of the head and neck and inhibition of proliferation by nonsteroidal anti-inflammatory drugs.
    Lee DW; Sung MW; Park SW; Seong WJ; Roh JL; Park B; Heo DS; Kim KH
    Anticancer Res; 2002; 22(4):2089-96. PubMed ID: 12174888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclin-dependent kinase 1 gene expression is associated with poor prognosis in gastric carcinoma.
    Masuda TA; Inoue H; Nishida K; Sonoda H; Yoshikawa Y; Kakeji Y; Utsunomiya T; Mori M
    Clin Cancer Res; 2003 Nov; 9(15):5693-8. PubMed ID: 14654553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclooxygenase-2 upregulates vascular endothelial growth factor expression and angiogenesis in human gastric carcinoma.
    Leung WK; To KF; Go MY; Chan KK; Chan FK; Ng EK; Chung SC; Sung JJ
    Int J Oncol; 2003 Nov; 23(5):1317-22. PubMed ID: 14532971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of p53 or p27 overexpression on cyclooxygenase-2 gene expression in head and neck squamous cell carcinoma cell lines.
    Lee DW; Park SW; Park SY; Heo DS; Kim KH; Sung MW
    Head Neck; 2004 Aug; 26(8):706-15. PubMed ID: 15287038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cyclooxygenase 2-selective inhibitor NS398 inhibits proliferation of oral carcinoma cell lines by mechanisms dependent and independent of reduced prostaglandin E2 synthesis.
    Minter HA; Eveson JW; Huntley S; Elder DJ; Hague A
    Clin Cancer Res; 2003 May; 9(5):1885-97. PubMed ID: 12738747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of p27 by S-phase kinase-associated protein 2 is associated with aggressiveness in non-small-cell lung cancer.
    Osoegawa A; Yoshino I; Tanaka S; Sugio K; Kameyama T; Yamaguchi M; Maehara Y
    J Clin Oncol; 2004 Oct; 22(20):4165-73. PubMed ID: 15483027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correlation of Skp2 and P27kip1 protein expression and clinicopathological features of prostate cancer].
    Zheng XY; Ding W; Xie LP; Chen ZD
    Ai Zheng; 2004 Feb; 23(2):215-8. PubMed ID: 14960249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclooxygenase-2 inhibitor NS398 enhances antitumor effect of irradiation on hormone refractory human prostate carcinoma cells.
    Wen B; Deutsch E; Eschwege P; De Crevoisier R; Nasr E; Eschwege F; Bourhis J
    J Urol; 2003 Nov; 170(5):2036-9. PubMed ID: 14532848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of growth inhibitory effects of cyclooxygenase-2 inhibitor-NS398 on cancer cells.
    Li S; Tong Q; Zhang W; Wang Q; Chen Z; Wu Q
    Cancer Invest; 2008 May; 26(4):333-7. PubMed ID: 18443952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclooxygenase-2 (COX-2)-dependent and -independent anticarcinogenic effects of celecoxib in human colon carcinoma cells.
    Maier TJ; Schilling K; Schmidt R; Geisslinger G; Grösch S
    Biochem Pharmacol; 2004 Apr; 67(8):1469-78. PubMed ID: 15041464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skp2 is oncogenic and overexpressed in human cancers.
    Gstaiger M; Jordan R; Lim M; Catzavelos C; Mestan J; Slingerland J; Krek W
    Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5043-8. PubMed ID: 11309491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific COX-2 inhibitor, NS-398, suppresses cellular proliferation and induces apoptosis in human hepatocellular carcinoma cells.
    Cheng AS; Chan HL; Leung WK; Wong N; Johnson PJ; Sung JJ
    Int J Oncol; 2003 Jul; 23(1):113-9. PubMed ID: 12792783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significant anti-proliferation of human endometrial cancer cells by combined treatment with a selective COX-2 inhibitor NS398 and specific MEK inhibitor U0126.
    Gao J; Niwa K; Takemura M; Sun W; Onogi K; Wu Y; Seishima M; Mori H; Tamaya T
    Int J Oncol; 2005 Mar; 26(3):737-44. PubMed ID: 15703831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COX-2 inhibitor, NS398, enhances Fas-mediated apoptosis via modulation of the PTEN-Akt pathway in human gastric carcinoma cell lines.
    Honjo S; Osaki M; Ardyanto TD; Hiramatsu T; Maeta N; Ito H
    DNA Cell Biol; 2005 Mar; 24(3):141-7. PubMed ID: 15767780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.